Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MD › KENSINGTON › INTERNATIONAL PEDIATRICS, P A

INTERNATIONAL PEDIATRICS, P A

NPI: 1235253485 · KENSINGTON, MD 20895 · Pediatrics Physician · NPI assigned 03/16/2007

$20.96M
Total Medicaid Paid
428,116
Total Claims
402,352
Beneficiaries
114
Codes Billed
2018-02
First Month
2024-12
Last Month

Provider Details

Authorized OfficialORTEGA, MARIO (PHYSICIAN)
NPI Enumeration Date03/16/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 63 $4K
2019 310 $10K
2020 64,809 $2.64M
2021 76,301 $3.70M
2022 98,059 $5.29M
2023 107,626 $5.32M
2024 80,948 $3.99M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 77,281 69,355 $6.78M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 14,458 13,582 $1.87M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 9,732 9,319 $1.35M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 12,410 12,177 $1.35M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 10,995 10,732 $1.19M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 9,202 8,935 $1.09M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 17,493 16,503 $970K
0240U 6,118 5,603 $819K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 7,202 6,700 $702K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 5,908 5,589 $576K
96110 Developmental screening, with scoring and documentation, per standardized instrument 32,740 31,132 $567K
92552 17,223 16,722 $426K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 10,716 10,140 $344K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 6,532 6,202 $326K
90686 13,976 13,502 $315K
90698 6,512 6,136 $143K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1,127 1,078 $131K
99205 Prolong outpt/office vis 600 511 $117K
90670 5,246 4,930 $115K
92551 10,473 10,253 $99K
90677 1,285 1,232 $86K
D1206 Topical application of fluoride varnish 3,623 3,348 $84K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,026 1,809 $81K
90680 3,677 3,427 $80K
94760 30,246 27,728 $73K
99173 28,136 27,392 $71K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 491 486 $69K
90651 2,873 2,796 $68K
90633 2,922 2,814 $66K
0071A 1,425 1,409 $56K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,749 1,646 $54K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,748 1,647 $54K
0072A 1,335 1,327 $53K
90744 2,196 2,081 $48K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,781 1,591 $42K
96160 14,003 13,566 $38K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 332 314 $37K
90619 1,322 1,284 $31K
0001A 785 774 $30K
90734 1,216 1,184 $28K
0002A 717 714 $28K
90715 1,108 1,065 $25K
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 2,794 2,747 $25K
90661 760 757 $22K
90621 712 693 $21K
2015F 1,457 1,383 $20K
90710 874 860 $20K
90696 857 840 $20K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,426 1,148 $19K
90620 784 741 $18K
90716 723 681 $16K
81000 5,660 5,375 $16K
3011F 1,734 1,713 $16K
99243 124 123 $16K
83655 1,326 1,280 $15K
91320 114 112 $14K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,075 1,040 $14K
96161 5,445 4,995 $14K
90480 328 325 $13K
0124A 328 318 $13K
90707 555 533 $12K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 146 145 $11K
0053A 264 254 $10K
69210 198 194 $8K
90656 357 357 $8K
91319 93 93 $8K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 398 369 $8K
99384 57 56 $8K
0154A 207 201 $7K
99383 58 57 $7K
85018 3,202 3,039 $7K
85014 2,907 2,761 $6K
0081A 134 126 $5K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 36 32 $5K
0073A 144 113 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 390 352 $4K
96127 558 515 $4K
0082A 96 90 $4K
0003A 85 82 $3K
87081 494 475 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 142 139 $3K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 31 31 $2K
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 347 312 $2K
91318 36 35 $2K
87634 43 41 $2K
84030 606 530 $2K
3008F 913 874 $2K
0004A 46 46 $2K
97802 64 61 $2K
99382 14 12 $1K
0052A 24 22 $880.00
80061 Lipid panel 65 62 $772.38
A7015 Aerosol mask, used with dme nebulizer 310 279 $635.93
94664 62 59 $574.00
0054A 14 14 $520.00
36416 4,837 3,609 $508.50
90674 21 21 $472.26
0051A 19 14 $440.00
36415 Collection of venous blood by venipuncture 201 191 $434.07
83036 Hemoglobin; glycosylated (A1C) 54 48 $376.65
99080 28 24 $320.00
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count 330 327 $269.00
99070 29 29 $239.78
99050 12 12 $182.26
99051 19 19 $160.00
86580 47 27 $159.18
86308 28 27 $128.32
99000 1,034 945 $54.30
82962 12 12 $28.72
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 377 339 $18.24
82948 12 12 $12.03
99072 85 76 $12.00
91300 180 171 $0.26
D0190 234 222 $0.00